BIOMAT Database Logo BIOMAT Database Logo

Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma. 2012

M Satoh, and M Vazquez-Del Mercado, and M E Krzyszczak, and Y Li, and A Ceribelli, and R W Burlingame, and T T Webb, and E S Sobel, and W H Reeves, and E K L Chan
Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Florida, Gainesville, USA. minoru.satoh@medicine.ufl.edu

Anti-RNA polymerase III (RNAP III) antibodies are highly specific for scleroderma (SSc) and associated with diffuse SSc and renal crisis. Coexistence of anti-RNAP III and other SSc autoantibodies is rarely documented. We report three cases with coexisting anti-RNAP III and anti-U1RNP. Autoantibodies in 3829 sera from rheumatology clinics were screened by immunoprecipitation. Anti-RNAP III-positive sera were also examined by immunofluorescence and anti-RNAP III ELISA. In total, 35 anti-RNAP III-positive sera were identified by immunoprecipitation, in which three had coexisting anti-U1RNP. All three were anti-RNAP III ELISA positive. Two had anti-RNAP I dominant (vs. RNAP III) reactivity and showed strong nucleolar staining. A case with anti-U1/U2RNP (U2RNP dominant) had systemic lupus erythematosus (SLE)-SSc overlap syndrome; however, the remaining two cases had SLE without signs of SSc. All three cases of anti-RNAP III + U1RNP fulfilled ACR SLE criteria but none in the group with anti-RNAP III alone (p = 0.0002). In contrast, only one case in the former group had sclerodermatous skin changes and Raynaud's phenomenon, vs. 92% with scleroderma in the latter (p < 0.05). Although anti-RNAP III is highly specific for SSc, cases with coexisting anti-U1RNP are not so uncommon among anti-RNAP III positives (8%, 3/35) and may be SLE without features of SSc.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D012320 RNA Polymerase III A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II. DNA-Dependent RNA Polymerase III,RNA Polymerase C,DNA Dependent RNA Polymerase III,Polymerase C, RNA,Polymerase III, RNA
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis
D017412 Ribonucleoprotein, U1 Small Nuclear A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U1 snRNP along with other small nuclear ribonucleoproteins (U2, U4-U6, and U5) assemble into SPLICEOSOMES that remove introns from pre-mRNA by splicing. The U1 snRNA forms base pairs with conserved sequence motifs at the 5'-splice site and recognizes both the 5'- and 3'-splice sites and may have a fundamental role in aligning the two sites for the splicing reaction. Small Nuclear Ribonucleoproteins, U1,U1 Small Nuclear Ribonucleoproteins,U1 snRNP,Ribonucleoproteins, Small, U1

Related Publications

M Satoh, and M Vazquez-Del Mercado, and M E Krzyszczak, and Y Li, and A Ceribelli, and R W Burlingame, and T T Webb, and E S Sobel, and W H Reeves, and E K L Chan
Predominance of IgM anti-U1RNP antibodies in patients with systemic lupus erythematosus.
June 1996, British journal of rheumatology,
M Satoh, and M Vazquez-Del Mercado, and M E Krzyszczak, and Y Li, and A Ceribelli, and R W Burlingame, and T T Webb, and E S Sobel, and W H Reeves, and E K L Chan
[Systemic lupus erythematosus with anti-centromere antibodies: An infrequent finding without scleroderma related features].
October 2016, Medicina clinica,
M Satoh, and M Vazquez-Del Mercado, and M E Krzyszczak, and Y Li, and A Ceribelli, and R W Burlingame, and T T Webb, and E S Sobel, and W H Reeves, and E K L Chan
Anti-RNA polymerase I antibodies in the urine of patients with systemic lupus erythematosus.
October 1990, The Journal of rheumatology,
M Satoh, and M Vazquez-Del Mercado, and M E Krzyszczak, and Y Li, and A Ceribelli, and R W Burlingame, and T T Webb, and E S Sobel, and W H Reeves, and E K L Chan
Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
February 2015, The Journal of dermatology,
M Satoh, and M Vazquez-Del Mercado, and M E Krzyszczak, and Y Li, and A Ceribelli, and R W Burlingame, and T T Webb, and E S Sobel, and W H Reeves, and E K L Chan
Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
April 2010, European journal of internal medicine,
M Satoh, and M Vazquez-Del Mercado, and M E Krzyszczak, and Y Li, and A Ceribelli, and R W Burlingame, and T T Webb, and E S Sobel, and W H Reeves, and E K L Chan
U1RNP positive neonatal lupus erythematosus: association with anti-La antibodies?
April 1995, The British journal of dermatology,
M Satoh, and M Vazquez-Del Mercado, and M E Krzyszczak, and Y Li, and A Ceribelli, and R W Burlingame, and T T Webb, and E S Sobel, and W H Reeves, and E K L Chan
[Anti-RNA polymerase III antibodies in scleroderma renal crisis].
June 2010, Deutsche medizinische Wochenschrift (1946),
M Satoh, and M Vazquez-Del Mercado, and M E Krzyszczak, and Y Li, and A Ceribelli, and R W Burlingame, and T T Webb, and E S Sobel, and W H Reeves, and E K L Chan
Coexistence of familial systemic lupus erythematosus and localized scleroderma.
November 1992, International journal of dermatology,
M Satoh, and M Vazquez-Del Mercado, and M E Krzyszczak, and Y Li, and A Ceribelli, and R W Burlingame, and T T Webb, and E S Sobel, and W H Reeves, and E K L Chan
Anti-dsDNA antibodies in sera of patients without systemic lupus erythematosus.
January 1984, Allergie und Immunologie,
M Satoh, and M Vazquez-Del Mercado, and M E Krzyszczak, and Y Li, and A Ceribelli, and R W Burlingame, and T T Webb, and E S Sobel, and W H Reeves, and E K L Chan
Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
July 2010, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!